한국발생생물학회지:발생과생식 (Development and Reproduction)

  • 제19권2호
  • /
  • Pages.111-118
  • /
  • 2015
  • /
  • 2465-9525(pISSN)
  • /
  • 2465-9541(eISSN)
한국발생생물학회 (The Korean Society of Developmental Biology)
권호 표지
DOI QR코드

DOI QR Code

Legislation on Genetic Diagnosis: Comparison of South Korea and Germany - With Focus on the Application and Communication Structure -

  • 투고 : 2015.05.22
  • 심사 : 2015.06.12
  • 발행 : 2015.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This article explores the questions regarding PND and PID, especially the concrete legal conditions for the justification of PND and PID. As such, the German law stipulating PND and PID in a very concrete and detailed manner is introduced and explained in comparison with the corresponding South Korean law. The South Korean Bioethics and Biosafety Act (BBA) stipulates various types of gene testing and does not demonstrate a delicate sense of each type of gene testing. In contrast to the South Korean regulation, in Germany, there exist specific regulations for genetic counseling. Especially in the case of PND, GEKO stipulates the process of genetic counseling very concretely, based on GenDG. In the case of PND and PID, it is important that the people concerned understand the meaning of testing in various angles, and restructuralize it by combining it with their own values as the diagnosis is directly combined with pregnancy/abortion, which influences the whole life of a woman (and her partner). In this context, the South Korean BBA needs to be amended as soon as possible. The sections on informed consent also need to be amended to make them more concrete. Furthermore, guidelines for concretizing the regulation of BBA need to be continuously formulated and developed.

키워드

참고문헌

  1. Cho S-Y (2007) Regulation of gene data bank by criminal process law in Germany. Criminology 19: 155-182.
  2. GEKO (Gendiagnostik Kommission am Robert Koch-Institut) (2011a) Richtlinie der Gendiagnostik-Kommission (GEKO) uber die Anforderungen an die Qualifikation zur und Inhalte der genetischen Beratung der gene-tischen Beratung gemaB ${\S}23$ Abs.2 Nr.2a und ${\S}23$ Abs.2 Nr.3 GenDG. Bundesgesundheitsblatt 54:1248-1256. https://doi.org/10.1007/s00103-011-1357-3
  3. GEKO (2013b) Richtlinie der Gendiagnostik-Kommission (GEKO) fur die Beurteilung genetischer Eigenschaften hinsichtlich ihrer Bedeutung nach ${\S}15$ Abs.1 Satz1 GenDG fur eine Beeintrachtigung der Gesundheit des Embryos oder des Fotus wahrend der Schwangerschaft oder nach der Geburt gemaB ${\S}23$ Abs.2 Nr.1d GenDG. Bundesgesundheitsblatt 56:1028-1029. https://doi.org/10.1007/s00103-013-1783-5
  4. GEKO (2013c) Bekanntnachung eines Beschlusses der Gendiagnostik-Kommission (GEKO) vom 16.11.2012 uber dier Anforderungen an die Inhalte der Aufklarung bei genetischen Untersuchungen zu medizinischen Zwecken gemaB ${\S}23$ Abs.2 Nr.3 GenDG vom 27.04. 2012. Bundesgesundheitsblatt 56:325-330. https://doi.org/10.1007/s00103-013-1677-6
  5. GEKO (2013a) Richtlinie der Gendiagnostik-Kommission (GEKO) fur die Anforderungen an die Durchfuhrung der vorge-burtlichen Risikoabklarung sowie an die insoweit erfor-derlichen MaBnahmen zur Qualitatssicherung gemaB ${\S}23$ Abs.2 Nr.5 GenDG. Bundesgesundheitsblatt 56:1023-1027. https://doi.org/10.1007/s00103-013-1782-6
  6. Jun M, Anderson G (2011) Models of genetic counseling services and quality assurance. Journal of Korean Academie Society of Nurse Education 17:524-535. https://doi.org/10.5977/JKASNE.2011.17.3.524
  7. Kim HJ (2011a) Genetic counseling in Korean health care system. Journal of Genetic Medicine 8:89-99. https://doi.org/10.5734/JGM.2011.8.2.89
  8. Kim N-K (2007a) Legal understanding of informed consent in medicine. Korean Journal of Medicine and Law 15(1):7-28.
  9. Kim N-K (2007b) Termination of pregnancy on the ground of fetal disability: the sociological structure and policy of law. Criminal Law Studies 19:127-165.
  10. Ministry of Health and Welfare & Centers for Disease Control and Prevention (2013) Guidelines for Management of Institutions associated with BBA, Dec 2013.